de VisserKarin E. Netherlands Cancer InstituteNetherlands

Prof. dr. Karin E. de Visser is senior group leader at the Division of Tumor Biology & Immunology at the Netherlands Cancer Institute, group leader at Oncode Institute and full professor of Experimental Immunobiology of Cancer at Leiden University Medical Center. Through mechanistic understanding of the crosstalk between the immune system and cancer, her lab aims to contribute to the design of novel immunomodulatory strategies to fight metastatic breast cancer. Her research group identified how mammary tumors induce a systemic inflammatory response that facilitates metastasis formation and how eosinophils contribute to immunotherapy response. Karin de Visser’s achievements include an ERC consolidator grant (2014), the Metastasis Research Prize of the Beug Foundation (2015), the 2025 Pezcoller-Marina Larcher Fogazzaro-EACR Women in Cancer Research Award, election as an EMBO young investigator (2016), and EMBO member (2021). She has served on the Research Management Committee of Oncode Institute (2018-2024) and now co-leads the research theme Immunotherapy at the NKI.